A Comparative Effect of Echogenic Needle for Nerve Block on Acute and Chronic Postoperative Pain
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: He Huang, ph.D
- Phone Number: 13708385559
- Email: huanghe@cqmu.edu.cn
Study Contact Backup
- Name: Da gang Wang, ph.D
- Phone Number: 023 63693014
- Email: kuanrenlunli@qq.com
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 4000000
- Recruiting
- He Huang
-
Contact:
- He Huang, ph.D
- Phone Number: 13708385559
- Email: huanghe@cqmu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The age is above 18 years old and below 70 years old.
- patients whose surgical sites were in the chest, abdomen, upper limbs or lower limbs, including lobectomy, cholecystectomy, gastrointestinal resection, hysterectomy and other elective operations.
- This operation was the first operation during the hospitalization.
- Consent to participate in this study and sign an informed consent form.
Exclusion Criteria:
- Patients with a history of alcohol or drug addiction.
- Patients with disturbance of consciousness before operation.
- Other conditions considered by the attending physician or researcher to be inappropriate for the study;
- History of chronic pain.
- Abnormal coagulation function.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Echogenic nerve block needle
Using a echogenic nerve block needle.
|
A 22G 8-cm echogenic nerve block needle (LEAPMED, CHINA) is selected for the procedure, administered under ultrasound guidance.
Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect.
The spread of the medication will be assessed through short- and long-axis imaging perspectives.
Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain.
Parameters such as the duration of nerve blockade, the incidence of punctures, and any associated complications are all meticulously appraised.
|
|
Other: Non-echogenic nerve block needle
Using a common nerve block needle.
|
A 22G 8-cm thin wall low bottom nerve block needle (KDL, CHINA) is selected for the procedure, administered under ultrasound guidance.
Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect.
The distribution of the medication will be assessed using short- and long-axis imaging perspectives.
Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain.
Parameters such as the duration of nerve blockade, the number of punctures, and any associated complications are all meticulously appraised.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chronic postoperative pain
Time Frame: The third month after surgery.
|
Incidence of Chronic pain assessment from 3 months after surgery
|
The third month after surgery.
|
|
Moderate to severe pain
Time Frame: from end of surgery to 24 hours after surgery.
|
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
|
from end of surgery to 24 hours after surgery.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acute postoperative pain
Time Frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
|
From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
|
Acute postoperative pain
Time Frame: From return to the ward to 12 hours after return to the ward
|
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
|
From return to the ward to 12 hours after return to the ward
|
|
Acute postoperative pain
Time Frame: From 12 hours after return to the ward to 24 hours after return to the ward
|
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
|
From 12 hours after return to the ward to 24 hours after return to the ward
|
|
Puncture operation time
Time Frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
Time from needle insertion to needle extraction
|
From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
|
Number of needle passes
Time Frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
The number of times the needle is withdrawn more than 2 cm and resited
|
From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: He Huang, ph.D, The Second Affiliated Hospital, Chongqing Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CPSP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.